{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:04:35Z","timestamp":1790229875740,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity and type 2 diabetes mellitus (T2DM) are associated with chronic metabolic dysregulation and microvascular complications, including diabetic peripheral neuropathy (DPN). This case series describes metabolic and patient reported outcomes during ongoing empagliflozin therapy with adjunctive acupuncture treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The prospective observational case series included three adult participants with obesity, T2DM, and symptom defined DPN. All participants received empagliflozin 10\u2005mg daily for at least 4 weeks before enrollment and continued treatment while receiving standardized acupuncture twice weekly for 10 weeks. Primary outcomes included body weight, body mass index (BMI), and waist circumference. Secondary outcomes included neuropathic pain intensity assessed using the visual analogue scale (VAS), sleep quality measured by a single-item sleep quality score, and fatigue assessed using the fatigue severity scale were recorded at baseline and week 10.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All participants completed the intervention without adverse events. The body weight decreased by 4\u20139\u2005kg, BMI by 1.2\u20133.5\u2005kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , and waist circumference by 5\u201310\u2005cm. VAS reduction range from 2 to 4 points, sleep quality and fatigue scores also improved consistently in all cases. Exploratory outcomes indicated enhanced mobility, reduced nocturnal neuropathic symptoms, and high treatment tolerability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combined therapy with SGLT2 inhibitors and acupuncture was associated with improvements in metabolic, neuropathic, and functional outcomes in obese patients with T2DM, and DPN. These findings suggest that a potential multidimensional therapeutic approach, however, larger controlled studies are required to confirm efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpain.2026.1886313","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:43:44Z","timestamp":1790228624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic and neuropathic outcomes following combined sodium-glucose cotransporter-2 inhibitor therapy and adjunctive acupuncture in obese patients with diabetic neuropathy: a case series"],"prefix":"10.3389","volume":"7","author":[{"given":"Yun Jin","family":"Kim","sequence":"first","affiliation":[{"name":"College of Medicine and Health Sciences, United Arab Emirates University","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1161521","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments","volume":"14","author":"Ruze","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"719515","DOI":"10.3389\/fendo.2021.719515","article-title":"Association between obesity and microvascular diseases in patients with type 2 diabetes mellitus","volume":"12","author":"Gao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1265372","DOI":"10.3389\/fendo.2023.1265372","article-title":"Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment","volume":"14","author":"Zhu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3390\/biomedicines12112518","article-title":"Evaluation of the impact of advanced glycation end-products on peripheral neuropathy outcomes in type 2 diabetes","volume":"12","author":"Singh","year":"2024","journal-title":"Biomedicines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","article-title":"Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.21037\/apm-22-693","article-title":"Diabetic peripheral neuropathy essentials: a narrative review","volume":"12","author":"Chang","year":"2023","journal-title":"Ann Palliat Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1136796","DOI":"10.3389\/fendo.2023.1136796","article-title":"Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.2337\/db2022-01","volume-title":"Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy","author":"Pop-Busui","year":"2022"},{"key":"B9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40200-025-01750-1","article-title":"Comprehensive insights into diabetic peripheral neuropathy: pathophysiology and therapeutic approaches","volume":"24","author":"Kumar","year":"2025","journal-title":"J Diabetes Metab Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S2213-8587(19)30081-6","article-title":"Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention","volume":"7","author":"Selvarajah","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2337\/dc24-2287","article-title":"Understanding the impact of diabetic peripheral neuropathy and neuropathic pain on quality of life and mental health in 6,960 people with diabetes","volume":"48","author":"Borbjerg","year":"2025","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12955-014-0171-7","article-title":"The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes","volume":"12","author":"Dermanovic Dobrota","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2147\/DMSO.S370050","article-title":"Painful diabetic peripheral neuropathy: practical guidance and challenges for clinical management","volume":"16","author":"Preston","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s11916-024-01293-9","article-title":"Diabetic neuropathy: a guide to pain management","volume":"28","author":"Zhang","year":"2024","journal-title":"Curr Pain Headache Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.2147\/DMSO.S212003","article-title":"Sodium-glucose cotransporter-2 (SGLT2) inhibitors: a clinician's guide","volume":"12","author":"Simes","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41594-023-01134-0","article-title":"Transport and inhibition mechanism of the human SGLT2-MAP17 glucose transporter","volume":"31","author":"Hiraizumi","year":"2024","journal-title":"Nat Struct Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41574-025-01170-4","article-title":"Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitors","volume":"21","author":"Lee","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1291450","DOI":"10.3389\/fcvm.2023.1291450","article-title":"The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy","volume":"10","author":"Su","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/13543784.2023.2263354","article-title":"SGLT2 inhibitors: an evidence-based update on cardiovascular implications","volume":"32","author":"Forzano","year":"2023","journal-title":"Expert Opin Invest Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","article-title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","volume":"12","author":"Usman","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.3390\/ijerph20176671","article-title":"Immunomodulatory effects of SGLT2 inhibitors-targeting inflammation and oxidative stress in aging","volume":"20","author":"Sch\u00f6nberger","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s13300-021-01104-z","article-title":"SGLT2 inhibitors and the clinical implications of associated weight loss in type 2 diabetes: a narrative review","volume":"12","author":"Jane\u017e","year":"2021","journal-title":"Diabetes Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12933-024-02539-x","article-title":"SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives","volume":"23","author":"Morciano","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"926717","DOI":"10.3389\/fphar.2022.926717","article-title":"The outcomes of sodium-glucose co-transporter 2 inhibitors (SGLT2I) on diabetes-associated neuropathy: a systematic review and meta-analysis","volume":"13","author":"Kandeel","year":"2022","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s13300-021-01004-2","article-title":"Sodium-glucose co-transporter 2 inhibitors (SGLT2i) exposure and outcomes in type 2 diabetes: a systematic review of population-based observational studies","volume":"12","author":"Caparrotta","year":"2021","journal-title":"Diabetes Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/medicina56010006","article-title":"Acupuncture for the relief of chronic pain: a synthesis of systematic reviews","volume":"56","author":"Paley","year":"2020","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/metabo14100542","article-title":"Impact of acupuncture on human metabolomic profiles: a systematic review","volume":"14","author":"Li","year":"2024","journal-title":"Metabolites"},{"key":"B29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.joim.2024.03.001","article-title":"Acupuncture for obesity and related diseases: insight for regulating neural circuit","volume":"22","author":"Jiang","year":"2024","journal-title":"J Integr Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"267959","DOI":"10.1155\/2013\/267959","article-title":"Acupuncture effect and central autonomic regulation","volume":"2013","author":"Li","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1038945","DOI":"10.3389\/fnins.2022.1038945","article-title":"The autonomic nervous system: a potential link to the efficacy of acupuncture","volume":"16","author":"Li","year":"2022","journal-title":"Front Neurosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.3390\/biomedicines10123258","article-title":"Diabetes-induced cardiac autonomic neuropathy: impact on heart function and prognosis","volume":"10","author":"Sudo","year":"2022","journal-title":"Biomedicines"},{"key":"B33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1090-3801(03)00090-9","article-title":"Peripheral effects of needle stimulation (acupuncture) on skin and muscle blood flow in fibromyalgia","volume":"8","author":"Sandberg","year":"2004","journal-title":"Eur J Pain"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1399925","DOI":"10.3389\/fneur.2024.1399925","article-title":"Neural circuit mechanisms of acupuncture effect: where are we now?","volume":"15","author":"Wang","year":"2024","journal-title":"Front Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6173412","DOI":"10.1155\/2019\/6173412","article-title":"Acupuncture-analgesia-mediated alleviation of central sensitization","volume":"2019","author":"Lai","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1704570","DOI":"10.3389\/fnhum.2026.1704570","article-title":"Decoding the mechanisms of acupuncture by neuroimaging: an integrated review from networks to molecules","volume":"20","author":"Liu","year":"2026","journal-title":"Front Hum Neurosci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2147\/JPR.S505312","article-title":"Exploration of key brain regions involved in acupuncture and moxibustion analgesia: an imaging-based study","volume":"18","author":"He","year":"2025","journal-title":"J Pain Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13020-021-00466-7","article-title":"The role of macrophage polarization and associated mechanisms in regulating the anti-inflammatory action of acupuncture: a literature review and perspectives","volume":"16","author":"Wang","year":"2021","journal-title":"Chin Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12906-025-05064-w","article-title":"Patients\u2019 experiences with acupuncture for diabetic polyneuropathy as part of a randomized controlled trial (ACUDPN)\u2014a qualitative study","volume":"25","author":"Bolster","year":"2025","journal-title":"BMC Complement Med Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12883-018-1037-0","article-title":"ACUDIN\u2014ACUpuncture and laser acupuncture for treatment of DIabetic peripheral Neuropathy: a randomized, placebo-controlled, partially double-blinded trial","volume":"18","author":"Meyer-Hamme","year":"2018","journal-title":"BMC Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4809125","DOI":"10.1155\/2020\/4809125","article-title":"Manual acupuncture or combination with vitamin B to treat diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials","volume":"2020","author":"Jiang","year":"2020","journal-title":"BioMed Res Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.5664\/jcsm.7478","article-title":"A new single-item sleep quality scale: results of psychometric evaluation in patients with chronic primary insomnia and depression","volume":"14","author":"Snyder","year":"2018","journal-title":"J Clin Sleep Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0022-3999(03)00371-4","article-title":"The assessment of fatigue: a practical guide for clinicians and researchers","volume":"56","author":"Dittner","year":"2004","journal-title":"J Psychosom Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/DMSO.S233538","article-title":"Extraglycemic effects of SGLT2 inhibitors: a review of the evidence","volume":"13","author":"Bonora","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e081109","DOI":"10.1136\/bmj-2024-081109","article-title":"Atypical diabetic neuropathies","volume":"390","author":"McCray","year":"2025","journal-title":"BMJ"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.2147\/JPR.S475351","article-title":"Pathophysiology of pain and mechanisms of neuromodulation: a narrative review (A Neuron Project)","volume":"17","author":"Karcz","year":"2024","journal-title":". J Pain Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41392-024-01845-w","article-title":"Pathology of pain and its implications for therapeutic interventions","volume":"9","author":"Cao","year":"2024","journal-title":"Signal Transduct Target Ther"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2026.1886313\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:43:46Z","timestamp":1790228626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2026.1886313\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":48,"alternative-id":["10.3389\/fpain.2026.1886313"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2026.1886313","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1886313"}}